Evidence map›Paper›PMID 30038627›Full record

ArticleFrontiers in immunology2018

Björn Rissiek, Marco Lukowiak, Friederike Raczkowski, Tim Magnus, Hans-Willi Mittrücker, Friedrich Koch-Nolte

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Animal Models for the Investigation of P2X7 Receptors.International journal of molecular sciences · 2023
    Review
  8. IRF4 is required for migration of CD4Frontiers in immunology · 2023
    Article
  9. Article
  10. Review
  11. CD8Nature reviews. Immunology · 2021
    Review
  12. Article
  13. Review
  14. Interferon regulatory factor 4 controls effector functions of CD8Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
  17. AiScience · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Björn RissiekDepartment of Neurology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Marco LukowiakDepartment of Neurology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Friederike RaczkowskiInstitute of Immunology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Tim MagnusDepartment of Neurology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Hans-Willi MittrückerInstitute of Immunology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Friedrich Koch-NolteInstitute of Immunology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Universität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On murine T cells, GPI-anchored ADP-ribosyltransferase 2.2 (ARTC2.2) ADP-ribosylates the P2X7 ion channel at arginine 125 in response to nicotinamide adenine dinucleotide (NAD

Indexed as

ADP-ribosylationARTC2.2nanobodiesP2X7tissue-resident memory T cells

Identifiers

PMID30038627
PMCPMC6046629
OpenAlexW2864895768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.